Cytokinetics
CYTK
CYTK
437 hedge funds and large institutions have $9.62B invested in Cytokinetics in 2026 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 175 increasing their positions, 133 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding in top 10
Funds holding in top 10: 15 → 16 (+1)
4.52% more ownership
Funds ownership: 114.08% → 118.59% (+4.5%)
2% more funds holding
Funds holding: 429 → 437 (+8)
Holders
437
Holding in Top 10
16
Calls
$551M
Puts
$214M
Top Buyers
| 1 | +$212M | |
| 2 | +$94.1M | |
| 3 | +$69.1M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$63.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$60.1M |
Top Sellers
| 1 | -$132M | |
| 2 | -$125M | |
| 3 | -$48.4M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$41.2M |
| 5 |
JP Morgan Chase
New York
|
-$32.3M |
